Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5956 to 5970 of 7691 results

  1. Pharmacological therapy for advanced liver fibrosis in children and young people:- What is the clinical and cost effectiveness of pharmacological therapy in children and young people with advanced liver fibrosis?

    Recommendation ID NG49/5 Question Pharmacological therapy for advanced liver fibrosis in children and young people:- What is the clinical

  2. Pharmacological treatments for headache prophylaxis to aid withdrawal treatment in medication overuse headache:- Does a course of steroid treatment or pharmacological treatments used for headache prophylaxis help people with medication overuse headaches withdraw from medication?

    Recommendation ID CG150/5 Question Pharmacological treatments for headache prophylaxis to aid withdrawal treatment in medication overuse

  3. What is the effectiveness of physical treatments (such as light devices) in the treatment of acne vulgaris or persistent acne vulgaris-related scarring?

    Recommendation ID NG198/5 Question What is the effectiveness of physical treatments (such as light devices) in the treatment of acne vulgaris

  4. What is the effectiveness of chemical peels for the treatment of acne vulgaris or persistent acne vulgaris-related scarring?

    Recommendation ID NG198/7 Question What is the effectiveness of chemical peels for the treatment of acne vulgaris or persistent acne vulgaris-related

  5. Physiotherapy:- Does physiotherapy started early in the course of Parkinson's disease, as opposed to after motor symptom onset, confer benefits in terms of delaying symptom onset and/or reducing severity?

    Recommendation ID NG71/5 Question Physiotherapy:- Does physiotherapy started early in the course of Parkinson's disease, as opposed to

  6. Is there a potential for dependence associated with pharmacological agents for neuropathic pain?

    Recommendation ID CG173/6 Question Is there a potential for dependence associated with pharmacological agents for neuropathic pain?

  7. Pizotifen to prevent recurrent migraine:- Is pizotifen a clinically and cost effective prophylactic treatment for recurrent migraine?

    Recommendation ID CG150/2 Question Pizotifen to prevent recurrent migraine:- Is pizotifen a clinically and cost effective prophylactic

  8. Potential for dependence associated with pharmacological drugs for neuropathic pain:- Is there a potential for dependence associated with pharmacological agents for neuropathic pain?

    Recommendation ID CG173/6 Question Potential for dependence associated with pharmacological drugs for neuropathic pain:- Is there a potential

  9. Point-of-care coagulation testing:- What is the clinical and cost effectiveness of point-of-care coagulation testing using rotational thromboelastometry (ROTEM) or thromboelastography (TEG) to target treatment, compared with standard laboratory coagulation testing?

    Recommendation ID NG39/1 Question Point-of-care coagulation testing:- What is the clinical and cost effectiveness of point-of-care coagulation

  10. What is the effectiveness, cost effectiveness and acceptability of social prescribing for carers?

    Recommendation ID NG150/5 Question What is the effectiveness, cost effectiveness and acceptability of social prescribing for carers?

  11. The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled appointments are filled and the effect on patients' experience before and after the introduction of point-of-care (POC) creatinine devices to radiology departments.

    Recommendation ID DG37/3 Question The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled

  12. What is the effectiveness, cost effectiveness and acceptability of carer passport schemes?

    Recommendation ID NG150/4 Question What is the effectiveness, cost effectiveness and acceptability of carer passport schemes? Any

  13. The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for use across the NHS in people presenting for an outpatient CT scan with contrast agent is developed or an existing tool is validated.

    Recommendation ID DG37/2 Question The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for

  14. Predicting life expectancy:- Is it possible to analyse primary care data to identify characteristics that affect life expectancy and to develop algorithms and prediction tools for patients and healthcare providers to predict reduced life expectancy?

    Recommendation ID NG56/4 Question Predicting life expectancy:- Is it possible to analyse primary care data to identify characteristics